Decibel Therapeutics, Inc. Deferred Offering Costs
Decibel Therapeutics, Inc. had Deferred Offering Costs of $0 as of 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2022-03-18
- 2021-12-31: Deferred Offering Costs $0.00.
- 2021-09-30: Deferred Offering Costs $0.00.
- 2021-06-30: Deferred Offering Costs $0.00.
- 2021-03-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-18 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-10 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 |